Johnson Johnson Company Top Insiders
| JNJ Stock | USD 243.37 0.04 0.02% |
Nearly 59% of Johnson Johnson's corporate insiders are selling. The analysis of insiders' sentiment of trading Johnson Johnson stock suggests that many insiders are alarmed at this time. Johnson Johnson employs about 138.2 K people. The company is managed by 54 executives with a total tenure of roughly 253 years, averaging almost 4.0 years of service per executive, having 2559.26 employees per reported executive.
| Jennifer Taubert Chairman Executive Vice President - Worldwide Chairman, Pharmaceuticals |
| Ashley McEvoy Chairman Executive Vice President - Worldwide Chairman, Medical Devices |
Insider Sentiment 41
Mostly Selling
Selling | Buying |
Latest Trades
| 2025-12-18 | Julie Johnson | Disposed @ 208.23 | |||
| 2025-12-09 | Lloyd Doggett | Acquired @ 199.99 | |||
| 2025-11-20 | Thomas H. Kean, Jr. | Disposed @ 203.29 | |||
| 2025-11-13 | Julie Johnson | Disposed @ 195.19 | |||
| 2025-11-07 | Ro Khanna | Acquired @ 186.5 | |||
| 2025-11-05 | Richard McCormick | Acquired @ 186.23 | |||
| 2025-10-31 | Lisa C. McClain | Disposed @ 189.02 | |||
| 2025-10-30 | Ro Khanna | Acquired @ 189.05 | |||
| 2025-09-29 | Ro Khanna | Acquired @ 181.63 | |||
| 2025-09-23 | Val T. Hoyle | Disposed @ 176.35 | |||
| 2025-09-04 | Jennifer L Taubert | Disposed 56471 @ 177.81 | View | ||
| 2025-08-19 | Kelly Morrison | Disposed @ 177.71 | |||
| 2025-08-14 | Julie Johnson | Disposed @ 174.96 | |||
| 2025-08-04 | Ro Khanna | Acquired @ 171.08 | |||
| 2025-07-31 | Thomas H. Kean, Jr. | Disposed @ 164.76 | |||
| 2025-07-25 | Ro Khanna | Acquired @ 168.29 | |||
| 2025-07-01 | Ro Khanna | Disposed @ 155.81 |
Monitoring Johnson Johnson's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Acquired vs Disposed
Filed vs Not Filed
Insider sentiment refers to the collective sentiment or feeling of Johnson Johnson's insiders - typically its officers, directors, and beneficial owners holding more than a certain percentage of the company's stock - about the future prospects of Johnson Johnson. This sentiment is often gauged based on the trading activities of these insiders. If insiders are purchasing more shares of their own company, it may be interpreted as a bullish sentiment, indicating that they believe Johnson Johnson's stock will rise in value. Conversely, if insiders are selling shares, it might be seen as bearish, suggesting they expect the stock price to drop.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. Johnson Johnson's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Johnson Johnson's future performance. Based on our forecasts, it is anticipated that Johnson will maintain a workforce of nearly 138200 employees by March 2026.Johnson Johnson's latest congressional trading
Congressional trading in companies like Johnson Johnson, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Johnson Johnson by those in governmental positions are based on the same information available to the general public.
| 2026-01-16 | Representative Julie Johnson | Acquired Under $15K | Verify | ||
| 2026-01-05 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2025-12-19 | Representative Thomas H Kean | Acquired $15K to $50K | Verify | ||
| 2025-12-12 | Representative Julie Johnson | Acquired Under $15K | Verify | ||
| 2025-12-10 | Representative Rich McCormick | Acquired Under $15K | Verify | ||
| 2025-11-24 | Representative Jared Moskowitz | Acquired Under $15K | Verify | ||
| 2025-11-14 | Representative Ro Khanna | Acquired Under $15K | Verify | ||
| 2025-10-10 | Representative Val Hoyle | Acquired Under $15K | Verify | ||
| 2025-10-05 | Representative Sheri Biggs | Acquired $15K to $50K | Verify | ||
| 2025-10-03 | Representative Ro Khanna | Acquired Under $15K | Verify | ||
| 2025-09-18 | Representative Rich McCormick | Acquired Under $15K | Verify | ||
| 2025-09-15 | Representative Lisa McClain | Acquired Under $15K | Verify | ||
| 2025-09-12 | Representative Kelly Louise Morrison | Acquired Under $15K | Verify | ||
| 2025-08-21 | Representative Thomas H Kean | Acquired $15K to $50K | Verify | ||
| 2025-06-23 | Representative Pete Sessions | Acquired $15K to $50K | Verify | ||
| 2025-02-11 | Representative Josh Gottheimer | Acquired Under $15K | Verify | ||
| 2025-01-15 | Representative Josh Gottheimer | Acquired Under $15K | Verify | ||
| 2025-01-07 | Representative Virginia Foxx | Acquired Under $15K | Verify | ||
| 2024-12-05 | Representative Josh Gottheimer | Acquired Under $15K | Verify | ||
| 2024-11-14 | Senator Tommy Tuberville | Acquired $15K to $50K | Verify | ||
| 2024-08-20 | Senator Sheldon Whitehouse | Acquired $15K to $50K | Verify | ||
| 2024-08-08 | Representative Richard W Allen | Acquired $15K to $50K | Verify | ||
| 2024-08-06 | Representative Jared Moskowitz | Acquired Under $15K | Verify | ||
| 2024-07-10 | Representative Richard W Allen | Acquired $15K to $50K | Verify | ||
| 2024-01-16 | Senator Jerry Moran | Acquired Under $15K | Verify | ||
| 2023-11-15 | Senator Tommy Tuberville | Acquired Under $15K | Verify | ||
| 2023-10-20 | Senator Pete Ricketts | Acquired $100K to $250K | Verify | ||
| 2023-10-04 | Representative John Curtis | Acquired Under $15K | Verify | ||
| 2023-10-02 | Senator Sheldon Whitehouse | Acquired Under $15K | Verify | ||
| 2023-09-22 | Senator Dan Sullivan | Acquired Under $15K | Verify | ||
| 2023-09-17 | Senator Dan Sullivan | Acquired Under $15K | Verify | ||
| 2023-08-26 | Representative Lois Frankel | Acquired Under $15K | Verify | ||
| 2023-03-20 | Representative Daniel Goldman | Acquired Under $15K | Verify | ||
| 2023-03-11 | Representative Thomas H Kean | Acquired $15K to $50K | Verify | ||
| 2023-03-02 | Representative Diana Harshbarger | Acquired Under $15K | Verify | ||
| 2023-02-17 | Representative Josh Gottheimer | Acquired Under $15K | Verify | ||
| 2023-02-11 | Representative Thomas H Kean | Acquired $15K to $50K | Verify | ||
| 2022-11-12 | Senator Shelley Moore Capito | Acquired Under $15K | Verify | ||
| 2022-09-02 | Representative Carol Devine Miller | Acquired $15K to $50K | Verify | ||
| 2022-07-08 | Representative John Curtis | Acquired Under $15K | Verify | ||
| 2022-06-29 | Representative Diana Harshbarger | Acquired Under $15K | Verify | ||
| 2022-06-09 | Representative Lois Frankel | Acquired Under $15K | Verify | ||
| 2022-06-03 | Representative Cynthia Axne | Acquired Under $15K | Verify | ||
| 2022-02-11 | Representative Pete Sessions | Acquired $15K to $50K | Verify | ||
| 2021-10-18 | Representative Robert J Wittman | Acquired Under $15K | Verify | ||
| 2021-10-15 | Senator Tommy Tuberville | Acquired Under $15K | Verify | ||
| 2021-10-14 | Senator Tommy Tuberville | Acquired Under $15K | Verify | ||
| 2021-07-23 | Senator Tommy Tuberville | Acquired Under $15K | Verify | ||
| 2021-07-22 | Senator Tommy Tuberville | Acquired Under $15K | Verify | ||
| 2021-07-15 | Representative Alan S Lowenthal | Acquired Under $15K | Verify | ||
| 2021-06-12 | Representative Richard W Allen | Acquired $15K to $50K | Verify | ||
| 2021-05-09 | Representative Marie Newman | Acquired $15K to $50K | Verify | ||
| 2021-02-12 | Representative Austin Scott | Acquired $15K to $50K | Verify | ||
| 2020-08-25 | Representative Bob Gibbs | Acquired Under $15K | Verify | ||
| 2020-07-31 | Representative Bill Pascrell | Acquired $15K to $50K | Verify | ||
| 2020-04-29 | Senator Shelley Moore Capito | Acquired Under $15K | Verify | ||
| 2020-04-28 | Senator Shelley Moore Capito | Acquired Under $15K | Verify | ||
| 2020-03-27 | Senator Bill Cassidy | Acquired Under $15K | Verify | ||
| 2020-01-14 | Representative Mike Gallagher | Acquired Under $15K | Verify | ||
| 2020-01-03 | Representative Mikie Sherrill | Acquired Under $15K | Verify | ||
| 2019-12-20 | Representative Lois Frankel | Acquired Under $15K | Verify | ||
| 2019-07-05 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2019-02-14 | Representative John A Yarmuth | Acquired Under $15K | Verify | ||
| 2018-11-08 | Senator Shelley Moore Capito | Acquired Under $15K | Verify | ||
| 2018-11-07 | Senator Shelley Moore Capito | Acquired Under $15K | Verify | ||
| 2018-06-26 | Representative Earl Blumenauer | Acquired Under $15K | Verify | ||
| 2018-06-22 | Representative Lois Frankel | Acquired Under $15K | Verify | ||
| 2017-11-07 | Senator Tammy Duckworth | Acquired Under $15K | Verify | ||
| 2017-07-03 | Senator James Inhofe | Acquired $50K to $100K | Verify | ||
| 2016-05-04 | Senator Shelley Moore Capito | Acquired Under $15K | Verify | ||
| 2016-05-03 | Senator Shelley Moore Capito | Acquired Under $15K | Verify |
Johnson Johnson Management Team Effectiveness
The company has Return on Asset of 0.0868 % which means that on every $100 spent on assets, it made $0.0868 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.3503 %, implying that it generated $0.3503 on every 100 dollars invested. Johnson Johnson's management efficiency ratios could be used to measure how well Johnson Johnson manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Johnson Johnson's Return On Tangible Assets are relatively stable compared to the past year. Return On Capital Employed is expected to hike to 0.25 this year, although the value of Return On Assets will most likely fall to 0.13. At this time, Johnson Johnson's Total Current Liabilities is relatively stable compared to the past year. Liabilities And Stockholders Equity is expected to hike to about 209.2 B this year, although the value of Change To Liabilities is projected to rise to (962.5 M).Common Stock Shares Outstanding is expected to hike to about 2.2 B this year, although the value of Net Income Applicable To Common Shares will most likely fall to nearly 14.7 B. Johnson Johnson has a total of 2.41 Billion outstanding shares. The majority of Johnson Johnson outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Johnson Johnson to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Johnson Johnson. Please pay attention to any change in the institutional holdings of Johnson Johnson as this could imply that something significant has changed or is about to change at the company. Please note that on January 16, 2026, Representative Julie Johnson of US Congress acquired under $15k worth of Johnson Johnson's common stock.
Shares in Circulation | First Issued 1985-09-30 | Previous Quarter 2.4 B | Current Value 2.4 B | Avarage Shares Outstanding 2.8 B | Quarterly Volatility 192.7 M |
Johnson Johnson Workforce Comparison
Johnson Johnson is currently regarded as number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 484,194. Johnson Johnson totals roughly 138,200 in number of employees claiming about 29% of equities under Health Care industry.
Johnson Johnson Profit Margins
The company has Net Profit Margin of 0.28 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.24 %, which entails that for every 100 dollars of revenue, it generated $0.24 of operating income.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.77 | 0.6882 |
|
| |||||
| Net Profit Margin | 0.43 | 0.4128 |
|
| |||||
| Operating Profit Margin | 0.18 | 0.2749 |
|
| |||||
| Pretax Profit Margin | 0.17 | 0.1769 |
|
| |||||
| Return On Assets | 0.13 | 0.2098 |
|
| |||||
| Return On Equity | 0.54 | 0.5111 |
|
|
Johnson Johnson Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Johnson Johnson insiders, such as employees or executives, is commonly permitted as long as it does not rely on Johnson Johnson's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Johnson Johnson insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2026-03-01 | 1.4 | 14 | 10 | 263,130 | 216,228 |
| 2025-12-01 | 2.5 | 5 | 2 | 23,559 | 43,442 |
| 2025-09-01 | 0.7778 | 7 | 9 | 211,303 | 438,458 |
| 2025-06-01 | 6.0 | 12 | 2 | 37,652 | 36,257 |
| 2025-03-01 | 0.8438 | 81 | 96 | 1,316,210 | 743,267 |
| 2024-12-01 | 4.0 | 4 | 1 | 70,378 | 68,835 |
| 2024-09-01 | 0.8 | 4 | 5 | 15,935 | 35,906 |
| 2024-06-01 | 3.2 | 16 | 5 | 64,664 | 69,533 |
| 2024-03-01 | 0.9367 | 74 | 79 | 1,126,871 | 841,041 |
| 2023-12-01 | 0.5 | 1 | 2 | 227.97 | 12,388 |
| 2023-09-01 | 0.25 | 2 | 8 | 14,927 | 64,213 |
| 2023-06-01 | 4.3333 | 13 | 3 | 89,364 | 12,520 |
| 2023-03-01 | 1.1064 | 52 | 47 | 1,560,338 | 1,435,117 |
| 2022-12-01 | 0.0563 | 17 | 302 | 424,982 | 808,031 |
| 2022-06-01 | 0.75 | 6 | 8 | 1,639 | 121,198 |
| 2022-03-01 | 0.6949 | 82 | 118 | 1,591,197 | 1,210,521 |
| 2021-12-01 | 1.0 | 4 | 4 | 5,804 | 22,640 |
| 2021-06-01 | 1.5 | 3 | 2 | 767.89 | 912.00 |
| 2021-03-01 | 1.3559 | 80 | 59 | 1,535,897 | 616,920 |
| 2020-12-01 | 1.0 | 4 | 4 | 55,444 | 130,274 |
| 2020-09-01 | 1.4 | 7 | 5 | 19,996 | 61,230 |
| 2020-03-01 | 1.0 | 90 | 90 | 2,022,671 | 1,394,742 |
| 2019-12-01 | 1.0 | 3 | 3 | 7,366 | 4,034 |
| 2019-09-01 | 1.0 | 1 | 1 | 382.39 | 2,692 |
| 2019-06-01 | 2.0 | 2 | 1 | 3,350 | 353.00 |
| 2019-03-01 | 1.0615 | 69 | 65 | 1,211,043 | 1,102,350 |
| 2018-12-01 | 0.7895 | 15 | 19 | 506,509 | 1,029,964 |
| 2018-09-01 | 0.2727 | 3 | 11 | 29,684 | 66,041 |
| 2018-06-01 | 2.0 | 2 | 1 | 757.75 | 385.00 |
| 2018-03-01 | 1.098 | 56 | 51 | 1,459,455 | 1,396,495 |
| 2017-12-01 | 1.0 | 4 | 4 | 76,454 | 119,787 |
| 2017-09-01 | 1.0 | 6 | 6 | 288,991 | 575,950 |
| 2017-06-01 | 4.0 | 4 | 1 | 1,313 | 409.00 |
| 2017-03-01 | 1.1077 | 72 | 65 | 2,208,599 | 1,395,624 |
| 2016-09-01 | 1.5 | 6 | 4 | 45,606 | 88,162 |
| 2016-06-01 | 0.8571 | 6 | 7 | 8,522 | 23,649 |
| 2016-03-01 | 1.2292 | 59 | 48 | 1,810,647 | 1,592,510 |
| 2015-12-01 | 0.8 | 8 | 10 | 72,335 | 128,397 |
| 2015-06-01 | 1.8 | 9 | 5 | 232,452 | 415,933 |
| 2015-03-01 | 1.7931 | 52 | 29 | 1,497,466 | 863,712 |
| 2014-12-01 | 1.625 | 13 | 8 | 124,081 | 80,120 |
| 2014-09-01 | 3.3333 | 10 | 3 | 31,463 | 60,936 |
| 2014-06-01 | 1.8571 | 13 | 7 | 26,671 | 50,018 |
| 2014-03-01 | 2.2273 | 49 | 22 | 1,595,007 | 270,290 |
| 2013-12-01 | 2.0 | 24 | 12 | 43,879 | 88,621 |
| 2013-09-01 | 1.5 | 18 | 12 | 151,479 | 218,390 |
| 2013-06-01 | 4.5 | 9 | 2 | 1,681 | 7,429 |
| 2013-03-01 | 2.8947 | 55 | 19 | 1,861,702 | 242,918 |
| 2012-12-01 | 1.3333 | 24 | 18 | 88,061 | 242,611 |
| 2012-09-01 | 1.3333 | 12 | 9 | 359,037 | 708,892 |
| 2012-03-01 | 3.8 | 38 | 10 | 2,001,830 | 1,040,386 |
| 2011-12-01 | 1.4 | 14 | 10 | 355,881 | 705,544 |
| 2011-06-01 | 2.0 | 8 | 4 | 331,325 | 658,300 |
| 2011-03-01 | 2.8333 | 34 | 12 | 1,078,290 | 147,164 |
| 2010-12-01 | 2.4 | 12 | 5 | 23,846 | 41,538 |
| 2010-09-01 | 1.5 | 12 | 8 | 268,351 | 529,534 |
| 2010-06-01 | 9.0 | 9 | 1 | 21,323 | 18,000 |
| 2010-03-01 | 3.3333 | 30 | 9 | 1,019,440 | 123,426 |
| 2009-12-01 | 1.3846 | 18 | 13 | 114,643 | 230,603 |
| 2009-09-01 | 2.1429 | 15 | 7 | 188,410 | 411,810 |
| 2009-06-01 | 2.75 | 11 | 4 | 41,599 | 80,840 |
| 2009-03-01 | 2.2381 | 47 | 21 | 1,229,737 | 244,806 |
| 2008-12-01 | 2.8571 | 20 | 7 | 76,055 | 98,292 |
| 2008-09-01 | 7.0 | 14 | 2 | 5,454 | 6,000 |
| 2008-06-01 | 0.5714 | 20 | 35 | 138,992 | 270,000 |
| 2008-03-01 | 4.8889 | 44 | 9 | 1,089,570 | 110,445 |
| 2007-12-01 | 0.9444 | 17 | 18 | 32,542 | 59,287 |
| 2007-09-01 | 11.0 | 11 | 1 | 2,422 | 2,640 |
| 2007-06-01 | 14.0 | 14 | 1 | 4,734 | 1,700 |
| 2007-03-01 | 4.6667 | 42 | 9 | 1,050,227 | 237,274 |
| 2006-12-01 | 0.8095 | 17 | 21 | 222,057 | 437,806 |
| 2006-09-01 | 1.4375 | 23 | 16 | 163,933 | 293,054 |
| 2006-06-01 | 2.2857 | 16 | 7 | 22,169 | 51,600 |
| 2006-03-01 | 7.1429 | 50 | 7 | 1,414,193 | 45,960 |
| 2005-12-01 | 2.0 | 18 | 9 | 72,595 | 95,869 |
| 2005-09-01 | 2.375 | 19 | 8 | 18,256 | 30,989 |
| 2005-06-01 | 4.4 | 22 | 5 | 68,622 | 109,600 |
| 2005-03-01 | 3.9 | 39 | 10 | 1,183,947 | 201,708 |
| 2004-12-01 | 3.3333 | 20 | 6 | 8,068 | 10,700 |
| 2004-09-01 | 1.9167 | 23 | 12 | 141,147 | 203,523 |
| 2004-06-01 | 5.5 | 22 | 4 | 52,068 | 89,200 |
| 2004-03-01 | 3.4737 | 66 | 19 | 1,467,963 | 540,524 |
| 2003-12-01 | 1.0 | 34 | 34 | 156,218 | 407,761 |
| 2003-09-01 | 7.3333 | 22 | 3 | 18,738 | 18,979 |
| 2003-06-01 | 4.3333 | 13 | 3 | 3,404 | 125,200 |
| 2003-03-01 | 1.0 | 1 | 1 | 26.00 | 13,800 |
Johnson Johnson Notable Stakeholders
A Johnson Johnson stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Johnson Johnson often face trade-offs trying to please all of them. Johnson Johnson's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Johnson Johnson's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jennifer Taubert | Executive Vice President - Worldwide Chairman, Pharmaceuticals | Profile | |
| Ashley McEvoy | Executive Vice President - Worldwide Chairman, Medical Devices | Profile | |
| Alex Gorsky | Chairman, CEO, Chairman of Executive Committee and Chairman of Fin. Committee | Profile | |
| Joaquin Duato | Executive Vice President Worldwide Chairman - Pharmaceuticals | Profile | |
| Thibaut Mongon | Executive Vice President, Worldwide Chairman, Consumer Health | Profile | |
| Paulus Stoffels | Worldwide Chairman of Pharmaceuticals, Chief Scientific Officer and Member of Executive Committee | Profile | |
| Jasmina Brooks | President Webster | Profile | |
| Michael Sneed | Executive Vice President - Global Corporate Affairs and Chief Communication Officer | Profile | |
| Kathryn Wengel | Executive Vice President Chief Global Supply Chain Officer | Profile | |
| James Swanson | Executive Vice President, Chief Information Officer | Profile | |
| Joseph Wolk | Chief Financial Officer, Executive Vice President | Profile | |
| Peter Fasolo | Chief Human Resource Officer, Executive Vice President | Profile | |
| Joseph CPA | Executive CFO | Profile | |
| Ronald Williams | Independent Director | Profile | |
| Anne Mulcahy | Lead Independent Director | Profile | |
| Ian Davis | Independent Director | Profile | |
| Mark Weinberger | Independent Director | Profile | |
| Jennifer Doudna | Independent Director | Profile | |
| Marillyn Hewson | Independent Director | Profile | |
| Mary Beckerle | Independent Director | Profile | |
| Darius Adamczyk | Independent Director | Profile | |
| Hubert Joly | Independent Director | Profile | |
| Mark McClellan | Independent Director | Profile | |
| Charles Prince | Independent Director | Profile | |
| Michael Ullmann | VP, General Counsel and Member of Executive Committee | Profile | |
| Duane Arsdale | Treasurer | Profile | |
| Neil Davie | Hypertension Pulmonary | Profile | |
| Nadja West | Independent Director | Profile | |
| Mark Larkins | Worldwide Secretary | Profile | |
| Joanne MD | Chief Officer | Profile | |
| Vanessa Broadhurst | Executive Vice President Global Corporate Affairs | Profile | |
| Bill Martin | Global Companies | Profile | |
| Penny MD | Office Head | Profile | |
| Tom Cavanaugh | Company Medicine | Profile | |
| D Davis | Independent Director | Profile | |
| Darren Snellgrove | Vice Relations | Profile | |
| A Washington | Independent Director | Profile | |
| Dirk Brinckman | Chief Officer | Profile | |
| Elizabeth JD | Executive Officer | Profile | |
| Michael Bodner | Global Recovery | Profile | |
| Susan MD | Vice Officer | Profile | |
| Hani Abouhalka | Company Digital | Profile | |
| Ahmet Tezel | Group RD | Profile | |
| Frederic MD | Chief Group | Profile | |
| Robert Decker | Controller Officer | Profile | |
| Mathai Mammen | Executive Vice President Pharmaceuticals, R&D | Profile | |
| Timothy Schmid | Executive MedTech | Profile | |
| William Hait | Executive Vice President Chief External Innovation, Medical Safety, Global Public Health Officer | Profile | |
| Jessica Moore | Vice Relations | Profile | |
| Celine Martin | Group CSS | Profile | |
| Kristen Mulholland | Executive Officer | Profile | |
| Elizabeth Forminard | Executive Counsel | Profile | |
| Guy MD | Group EMEA | Profile | |
| David Lee | Immunology Head | Profile |
About Johnson Johnson Management Performance
The success or failure of an entity such as Johnson Johnson often depends on how effective the management is. Johnson Johnson management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Johnson management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Johnson management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.36 | 0.38 | |
| Return On Capital Employed | 0.19 | 0.25 | |
| Return On Assets | 0.21 | 0.13 | |
| Return On Equity | 0.51 | 0.54 |
Johnson Johnson Workforce Analysis
Traditionally, organizations such as Johnson Johnson use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Johnson Johnson within its industry.Johnson Johnson Manpower Efficiency
Return on Johnson Johnson Manpower
| Revenue Per Employee | 681.6K | |
| Revenue Per Executive | 1.7B | |
| Net Income Per Employee | 194K | |
| Net Income Per Executive | 496.4M | |
| Working Capital Per Employee | 10.8K | |
| Working Capital Per Executive | 27.7M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
What growth prospects exist in Pharmaceuticals sector? Can Johnson capture new markets? Factors like these will boost the valuation of Johnson Johnson. Expected growth trajectory for Johnson significantly influences the price investors are willing to assign. Valuation analysis balances hard financial data with qualitative growth assessments. While each Johnson Johnson valuation metric matters, prioritizing which indicators carry greater predictive weight remains essential.
Quarterly Earnings Growth 0.486 | Dividend Share 5.14 | Earnings Share 11.03 | Revenue Per Share | Quarterly Revenue Growth 0.091 |
Understanding Johnson Johnson requires distinguishing between market price and book value, where the latter reflects Johnson's accounting equity. The concept of intrinsic value - what Johnson Johnson's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investment professionals apply varied valuation frameworks to compute inherent worth and acquire positions when market prices trade at discounts to calculated value. Market sentiment, economic cycles, and investor behavior can push Johnson Johnson's price substantially above or below its fundamental value.
Understanding that Johnson Johnson's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Johnson Johnson represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Johnson Johnson's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.